Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.6.99.5 (
NADH dehydrogenase
)
2,135
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
MWFE
polypeptide of mammalian complex I (the proton-translocating
NADH-quinone oxidoreductase
) is 70 amino acids long, and it is predicted to be a membrane protein. The
NDUFA1
gene encoding the
MWFE
polypeptide is located on the X chromosome. This polypeptide is 1 of approximately 28 "accessory proteins" identified in complex I, which is composed of 42 unlike subunits. It was considered accessory, because it is not one of the 14 polypeptides making up the core complex I; a homologous set of 14 polypeptides can make a fully functional proton-translocating
NADH-quinone oxidoreductase
in prokaryotes. One
MWFE
mutant has been identified and isolated from a collection of respiration-deficient Chinese hamster cell mutants. The CCL16-B2 mutant has suffered a deletion that would produce a truncated and abnormal
MWFE
protein. In these mutant cells, complex I activity is reduced severely (<10%). Complementation with hamster
NDUFA1
cDNA restored the rotenone-sensitive complex I activity of these mutant cells to approximately 100% of the parent cell activity. Thus, it is established that the
MWFE
polypeptide is absolutely essential for an active complex I in mammals.
...
PMID:The NDUFA1 gene product (MWFE protein) is essential for activity of complex I in mammalian mitochondria. 1020 Feb 66
Skin pigmentation is caused by various physical and chemical factors. It might also be influenced by changes in the physiological function of skin with aging. Nicotinamide adenine dinucleotide (NADH) dehydrogenase is an enzyme related to the mitochondrial electron transport system and plays a key role in cellular energy production. It has been reported that the functional decrease in this system causes Parkinson's disease. Another study reports that the amount of
NADH dehydrogenase
in heart and skeletal muscle decreases with aging. A similar decrease in the skin would probably affect its physiological function. However, no reports have examined the age-related change in levels of
NADH dehydrogenase
in human skin. In this study, we investigated this change and its effect on skin pigmentation using cultured human epidermal keratinocytes. The mRNA expression of
NDUFA1
, NDUFB7, and NDUFS2, subunits of
NADH dehydrogenase
, and its activity were significantly decreased in late passage keratinocytes compared to early passage cells. Conversely, the mRNA expression of melanocyte-stimulating cytokines, interleukin-1 alpha and endothelin 1, was increased in late passage cells. On the other hand, the inhibition of
NADH dehydrogenase
upregulated the mRNA expression of melanocyte-stimulating cytokines. Moreover, the level of NDUFB7 mRNA was lower in pigmented than in nonpigmented regions of skin in vivo. These results suggest the decrease in
NADH dehydrogenase
with aging to be involved in skin pigmentation.
...
PMID:Decrease in nicotinamide adenine dinucleotide dehydrogenase is related to skin pigmentation. 2236 Mar 28